Comparison of effects of dalteparin and enoxaparin on hemostatic parameters and von Willebrand factor in patients with unstable angina pectoris or non--ST- segment elevation acute myocardial infarction
- PMID: 11867046
- DOI: 10.1016/s0002-9149(01)02300-1
Comparison of effects of dalteparin and enoxaparin on hemostatic parameters and von Willebrand factor in patients with unstable angina pectoris or non--ST- segment elevation acute myocardial infarction
Similar articles
-
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).Am J Cardiol. 2003 Apr 15;91(8):925-30. doi: 10.1016/s0002-9149(03)00105-x. Am J Cardiol. 2003. PMID: 12686329 Clinical Trial.
-
Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina.J Am Coll Cardiol. 2000 Jul;36(1):110-4. doi: 10.1016/s0735-1097(00)00695-1. J Am Coll Cardiol. 2000. PMID: 10898421 Clinical Trial.
-
Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.Circulation. 1998 Jul 28;98(4):294-9. doi: 10.1161/01.cir.98.4.294. Circulation. 1998. PMID: 9711933 Clinical Trial.
-
Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update.Drugs. 2002;62(12):1755-70. doi: 10.2165/00003495-200262120-00005. Drugs. 2002. PMID: 12149045 Review.
-
Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non-Q-wave acute myocardial infarction.Am J Cardiol. 2000 Apr 27;85(8A):2C-9C. doi: 10.1016/s0002-9149(00)00879-1. Am J Cardiol. 2000. PMID: 10793174 Review.
Cited by
-
Pharmacodynamic and pharmacokinetic properties of enoxaparin : implications for clinical practice.Clin Pharmacokinet. 2003;42(12):1043-57. doi: 10.2165/00003088-200342120-00003. Clin Pharmacokinet. 2003. PMID: 12959635 Review.
-
Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.P T. 2010 Feb;35(2):95-105. P T. 2010. PMID: 20221326 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical